Quantitative and volumetric European Association for the Study of the Liver and Response Evaluation Criteria in Solid Tumors measurements: feasibility of a semiautomated software method to assess tumor response after transcatheter arterial chemoembo
about
Systematic review of catheter-based intra-arterial therapies in hepatocellular carcinoma: state of the art and future directionsAssessment of clinical and radiological response to sorafenib in hepatocellular carcinoma patientsEvaluation of CT vascularization patterns for survival prognosis in patients with hepatocellular carcinoma treated by conventional TACE.Imaging Biomarkers of Tumor Response in Neuroendocrine Liver Metastases Treated with Transarterial Chemoembolization: Can Enhancing Tumor Burden of the Whole Liver Help Predict Patient Survival?Uveal Melanoma Metastatic to the Liver: The Role of Quantitative Volumetric Contrast-Enhanced MR Imaging in the Assessment of Early Tumor Response after Transarterial Chemoembolization.Radiologic-pathologic analysis of contrast-enhanced and diffusion-weighted MR imaging in patients with HCC after TACE: diagnostic accuracy of 3D quantitative image analysisTransarterial chemoembolization in soft-tissue sarcoma metastases to the liver - the use of imaging biomarkers as predictors of patient survivalFunctional magnetic resonance imaging response of targeted tumor burden and its impact on survival in patients with hepatocellular carcinoma.Identifying Staging Markers for Hepatocellular Carcinoma before Transarterial Chemoembolization: Comparison of Three-dimensional Quantitative versus Non-three-dimensional Imaging MarkersThree-Dimensional Quantitative Assessment of Uterine Fibroid Response after Uterine Artery Embolization Using Contrast-Enhanced MR Imaging.Early survival prediction after intra-arterial therapies: a 3D quantitative MRI assessment of tumour response after TACE or radioembolization of colorectal cancer metastases to the liver.Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis.Multimodality 3D Tumor Segmentation in HCC Patients Treated with TACE.Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.Radiologic-pathologic analysis of quantitative 3D tumour enhancement on contrast-enhanced MR imaging: a study of ROI placement.Comparison of Existing Response Criteria in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Using a 3D Quantitative Approach.Novel imaging biomarkers of response to transcatheter arterial chemoembolization in hepatocellular carcinoma patients.Semiautomatic volumetric tumor segmentation for hepatocellular carcinoma: comparison between C-arm cone beam computed tomography and MRI.3D Quantitative tumour burden analysis in patients with hepatocellular carcinoma before TACE: comparing single-lesion vs. multi-lesion imaging biomarkers as predictors of patient survival.Interreader and inter-test agreement in assessing treatment response following transarterial embolization for hepatocellular carcinomaRenal Cell Carcinoma Metastatic to the Liver: Early Response Assessment after Intraarterial Therapy Using 3D Quantitative Tumor Enhancement Analysis.Three-dimensional evaluation of lipiodol retention in HCC after chemoembolization: a quantitative comparison between CBCT and MDCT.Imaging tumor response following liver-directed intra-arterial therapy.Intraarterial therapies for primary liver cancer: state of the art.Assessing tumor response after loco-regional liver cancer therapies: the role of 3D MRI.Assessment of radiologic response to targeted therapies in patients with hepatocellular carcinoma.Hepatic imaging following intra-arterial embolotherapy.Interventional Oncology in Hepatocellular Carcinoma: Progress Through Innovation.New concepts in embolotherapy of HCC.Intra-arterial therapies for liver cancer: assessing tumor response.Parametric response mapping of dynamic CT: enhanced prediction of survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.The impact of antiangiogenic therapy combined with Transarterial Chemoembolization on enhancement based quantitative tumor response assessment in patients with hepatocellular carcinoma.Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy.Which Criteria Applied in Multi-Phasic CT Can Predict Early Tumor Response in Patients with Hepatocellular Carcinoma Treated Using Conventional TACE: RECIST, mRECIST, EASL or qEASL?Predicting Treatment Response to Intra-arterial Therapies for Hepatocellular Carcinoma with the Use of Supervised Machine Learning-An Artificial Intelligence Concept.Response stratification and survival analysis of hepatocellular carcinoma patients treated with intra-arterial therapy using MR imaging-based arterial enhancement fraction.Transarterial embolization and low-dose continuous hepatic arterial infusion chemotherapy with oxaliplatin and raltitrexed for hepatocellular carcinoma with major portal vein tumor thrombus.Hepatocellular Carcinoma: Diagnosis, Treatment Algorithms, and Imaging Appearance after Transarterial Chemoembolization.
P2860
Q27007847-DC9BBF3E-F782-4096-A443-EB864289C7FCQ28086977-38186AB1-1931-4E16-BF0F-81157DAF2667Q33620645-DEFED0D8-3229-416A-8913-7BEFC6B7D971Q33658301-5824E741-2E71-479A-B533-609307DAE644Q34369283-4537A20F-A9E3-4453-88CE-6EB2064DFFB0Q34680081-5E711E34-10BF-48E0-B1D9-87BC24EBCFB4Q35044274-6CBDC994-71D4-4ED2-BACF-3EEC769F00B0Q35163735-BCA6BC40-45EA-49DD-9DBA-8CDE099CA8B6Q35537007-CCFC7EE9-4D7B-45E9-9FED-DDA79E1CF246Q35554094-CAFE3892-C616-43A9-8A0C-1E5DD6674349Q35691040-CCBD0A4A-F7C1-425B-99FE-132D257A78EFQ35731141-5EC36497-E504-4D4B-AB7A-C9518F79E41BQ35732421-98DE23DD-C705-4E55-99E5-BF528A63E617Q36296750-1DDA3FC4-1598-4433-ADF3-0EB5CC7F0116Q36304428-A060DDAA-26D1-4320-976E-CCF54C6EDF32Q36416250-89E888B4-DC08-44F9-9890-77D3B223EF2CQ36419100-2B119F84-BA63-4A38-962A-FD757797D0A5Q36700219-5CD4FA61-4747-4F07-81B6-3CFCF3FAC4C3Q37088693-2B2468EC-66F7-45A3-9EDC-5BC7D824BC4FQ37143017-8DB0C0D8-C90E-4B13-B1E8-1FEB9766FBF3Q37253841-E3D030B5-7E49-49CE-B31D-64C37C1FF624Q37692610-74EA0869-F492-48C4-81A0-75FA94C5574EQ38117579-E177973E-59BA-4993-825B-03E3F61B80EFQ38149993-CB4B69EA-FDC5-4A2F-9B4F-49E1D2777220Q38265114-1402059C-F09B-4A24-A8BF-C5BFCF317421Q38268169-2BE31D34-613E-4DA3-9339-180CA9B7B414Q38716483-BD6DC173-736A-43E9-A761-5C17B7C9D042Q38792625-C79DC366-0D1B-443C-AAFA-683A53532BE8Q38904263-9F55A744-ED70-4833-AB1B-CF44F68BBC46Q39041266-730BB773-4050-435D-98D2-64B674F7E6DFQ40333754-0B5182DC-2792-49CB-82FC-48A7A35B0B17Q47967037-DEE9BACB-CAD5-452D-9D83-D40514FA6AA1Q48165156-467BD146-55F2-4D5E-86B0-A77FEF721926Q50223119-5C395E5F-B965-4735-B7C8-5F81C41E9600Q52651474-730B0BC3-9B74-411C-BCC2-A03401231BF0Q53089236-BC7FEAA2-51B0-4E6E-A3A5-73483C1ECD22Q55276054-0E183993-5A2E-4C98-97A1-E3F0DE21D375Q55312644-1EF5DE7F-2C52-4317-84C7-D18F06EFBADE
P2860
Quantitative and volumetric European Association for the Study of the Liver and Response Evaluation Criteria in Solid Tumors measurements: feasibility of a semiautomated software method to assess tumor response after transcatheter arterial chemoembo
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Quantitative and volumetric Eu ...... anscatheter arterial chemoembo
@ast
Quantitative and volumetric Eu ...... anscatheter arterial chemoembo
@en
type
label
Quantitative and volumetric Eu ...... anscatheter arterial chemoembo
@ast
Quantitative and volumetric Eu ...... anscatheter arterial chemoembo
@en
prefLabel
Quantitative and volumetric Eu ...... anscatheter arterial chemoembo
@ast
Quantitative and volumetric Eu ...... anscatheter arterial chemoembo
@en
P2093
P2860
P1476
Quantitative and volumetric Eu ...... anscatheter arterial chemoembo
@en
P2093
Benoit Mory
Diane K Reyes
Jean-François Geschwind
MingDe Lin
Nikhil Bhagat
Olivier Pellerin
Pramod P Rao
Roberto Ardon
Romaric Loffroy
P2860
P304
P356
10.1016/J.JVIR.2012.08.028
P577
2012-12-01T00:00:00Z